Cell and Gene Therapy Advisors (CaGTA)
Accelerating Advanced Therapies from Concept to Commercialization
About CaGTA
Cell and Gene Therapy Advisors (CaGTA) provides specialized biotechnology consulting for organizations developing advanced cell and gene therapies. Founded by Dr. Vladimir Slepushkin, the company leverages decades of leadership experience in CAR-T cell manufacturing, viral vector development, process optimization, and technology transfer. We help clients accelerate innovation and achieve critical development milestones while navigating the complex landscape of therapeutic development.
Dr. Slepushkin brings extensive expertise from senior leadership roles at MedTherapy Biotechnology, Autolus Therapeutics, Kite Pharma, and Novartis, where he led manufacturing, process development, quality systems, regulatory submissions, and clinical product development. CaGTA helps biotechnology companies build scalable, high-quality therapeutic programs by providing strategic guidance on technical challenges, regulatory compliance, and operational excellence from concept through commercialization.
Our Services
Cell & Gene Therapy Manufacturing Consulting
Strategic guidance for CAR-T cell and viral vector manufacturing, production scale-up, and operational excellence. We provide expert support in optimizing manufacturing processes, ensuring quality standards, and achieving manufacturing readiness for clinical and commercial production.
Process Development & Technology Transfer
Comprehensive expertise in viral vector development, assay development, process optimization, and manufacturing readiness. Our team guides organizations through technology transfer initiatives to ensure seamless scale-up and successful transition from development to manufacturing.
Regulatory & Clinical Development Strategy
Support for CMC submissions, GMP compliance, quality systems, and clinical development planning. We help organizations navigate regulatory pathways, establish robust quality frameworks, and develop comprehensive strategies for successful clinical trials and regulatory approvals.